This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Taylor Hickman in Cancer Treatment
Introduction
Taylor Hickman is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on developing compositions that target BCMA, a crucial protein involved in certain types of cancer.
Latest Patents
Taylor Hickman holds a patent for "Compositions targeting BCMA and methods of use thereof." This invention relates to BCMA binders, such as antibodies, and chimeric antigen receptor (CAR) constructs that include a BCMA antigen binding molecule. The BCMA binders are designed to specifically bind to BCMA, enhancing the efficacy of NK cells in killing cancer cells. The patent also outlines therapeutic uses for these BCMA binders and CARs, showcasing their potential in cancer therapies.
Career Highlights
Taylor Hickman is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research in oncology. His work has garnered attention for its innovative approach to targeting cancer cells more effectively.
Collaborations
Some of his notable coworkers include Michael David Curley and Ertan Eryilmaz, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Taylor Hickman's innovative work in developing BCMA-targeting therapies represents a significant advancement in cancer treatment. His contributions are paving the way for more effective therapeutic options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile